Category: investment
-
Six Ways White House Proposes to Bring Domestic Drug Supply Back to US
The proposal outlined in a new Biden White House white paper involves policy considerations that are estimated to cost between $3.26 billion and $5.11 billion over a span of 10 years. This funding is aimed at improving the supply of generic sterile injectable medicines and enhancing the resilience of drug supply chains.
-
Biden Proposes Strategy to Combat Drug Shortages Through Supply Chain Resilience
In a move aimed at addressing persistent drug shortages and enhancing supply chain resilience, the White House recently unveiled an 18-page white paper proposing a novel strategy.